NCT02770079

Brief Summary

Aim of the study: To define insulin requirement during pregnancy and to identify the rapid changes in insulin sensitivity around parturition and the first 6 months post partum. Such knowledge would be clinically useful and markedly improve insulin treatment before and after parturition for women with type 1 diabetes and serve to identify the best possible timing of testing women with gestational diabetes mellitus (GDM) for the development of type 2 diabetes post partum. Method: Botnia clamp in women before, immediately after delivery and 6 months post partum. The investigators will compare 20 women with GDM in late pregnancy, day 15 post partum and 6 months post partum with 20 normal women investigated at the same time points. In addition the investigators will collect feces samples from the mother and baby in order to determine microbiota. Perspectives: Diabetes is a common condition with important implications for pregnancy outcome and long-term morbidity for mother and offspring. Accordingly, tailoring the best treatment is expected to have beneficial consequences both for the pregnant women and the future generation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started May 2016

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 1, 2016

Completed
Same day until next milestone

Study Start

First participant enrolled

May 1, 2016

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 12, 2016

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2019

Completed
Last Updated

September 27, 2019

Status Verified

September 1, 2019

Enrollment Period

3.2 years

First QC Date

May 1, 2016

Last Update Submit

September 25, 2019

Conditions

Keywords

Insulin sensitivity

Outcome Measures

Primary Outcomes (1)

  • Change in insulin sensitivity

    Performing a Botnia clamp 3 times around parturition on women with GDM and comparing them with women with no GDM. The women will be their own control prospectively but also compared with a control group without gestational diabetes in order to compared them cross sectionally

    Determined one time between gestational week 32 to 37, 14 days postpartum and 6 months postpartum.

Secondary Outcomes (1)

  • Changes in the microbiota

    Determined one time between gestational week 32 to 37 (only the mother), 14 days postpartum and 6 months postpartum.

Study Arms (1)

Gestational diabetes

10 women with gestational diabetes

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

All women visiting the outpatient gestational diabetes clinic at Aarhus University Hospital will be approached.

You may qualify if:

  • Written consent before study start.
  • Pregnant.
  • GDM for the GDM group.
  • No diabetes for the control group.

You may not qualify if:

  • Women with multiple pregnancy.
  • New pregnancy before all three examinations has been done.
  • Severe, debilitating, concurrent diseases.
  • Serious or intolerable adverse reactions associated with the studies.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aarhus University Hospital, NBG

Aarhus, 8000, Denmark

Location

Related Publications (1)

  • Skajaa GO, Fuglsang J, Knorr S, Moller N, Ovesen P, Kampmann U. Changes in insulin sensitivity and insulin secretion during pregnancy and post partum in women with gestational diabetes. BMJ Open Diabetes Res Care. 2020 Oct;8(2):e001728. doi: 10.1136/bmjdrc-2020-001728.

Biospecimen

Retention: SAMPLES WITH DNA

Whole blood approximately 10 mL.

MeSH Terms

Conditions

Diabetes, GestationalInsulin Resistance

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesHyperinsulinism

Study Officials

  • Per G Ovesen, MD, DMSc

    University of Aarhus

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 1, 2016

First Posted

May 12, 2016

Study Start

May 1, 2016

Primary Completion

July 1, 2019

Study Completion

September 1, 2019

Last Updated

September 27, 2019

Record last verified: 2019-09

Locations